David Joshua Bartch - Net Worth and Insider Trading
David Joshua Bartch Net Worth
The estimated net worth of David Joshua Bartch is at least $10,000 dollars as of 2024-09-23. David Joshua Bartch is the Director of Mydecine Innovations Group Inc and owns about 1,000,000 shares of Mydecine Innovations Group Inc (XCNQ:MYCO) stock worth over $10,000. Details can be seen in David Joshua Bartch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Joshua Bartch has not made any transactions after 2024-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Joshua Bartch
David Joshua Bartch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Joshua Bartch owns 1 companies in total, including Mydecine Innovations Group Inc (XCNQ:MYCO) .
Click here to see the complete history of David Joshua Bartch’s form 4 insider trades.
Insider Ownership Summary of David Joshua Bartch
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
XCNQ:MYCO | Mydecine Innovations Group Inc | 2024-01-08 | Director |
David Joshua Bartch Latest Holdings Summary
David Joshua Bartch currently owns a total of 1 stock. David Joshua Bartch owns 1,000,000 shares of Mydecine Innovations Group Inc (XCNQ:MYCO) as of January 8, 2024, with a value of $10,000.
Latest Holdings of David Joshua Bartch
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XCNQ:MYCO | Mydecine Innovations Group Inc | 2024-01-08 | 1,000,000 | 0.01 | 10,000 |
Holding Weightings of David Joshua Bartch
David Joshua Bartch Form 4 Trading Tracker
According to the SEC Form 4 filings, David Joshua Bartch has made a total of 2 transactions in Mydecine Innovations Group Inc (XCNQ:MYCO) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Mydecine Innovations Group Inc is the acquisition of 500,000 shares on January 8, 2024, which cost David Joshua Bartch around $15,000.
Insider Trading History of David Joshua Bartch
- 1
David Joshua Bartch Trading Performance
GuruFocus tracks the stock performance after each of David Joshua Bartch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Joshua Bartch is -33.33%. GuruFocus also compares David Joshua Bartch's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Joshua Bartch within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Joshua Bartch's insider trading performs compared to the benchmark.
Performance of David Joshua Bartch
David Joshua Bartch Ownership Network
David Joshua Bartch Owned Company Details
What does Mydecine Innovations Group Inc do?
Who are the key executives at Mydecine Innovations Group Inc?
David Joshua Bartch is the Director of Mydecine Innovations Group Inc. Other key executives at Mydecine Innovations Group Inc include and Senior Officer Damon Michaels .
Mydecine Innovations Group Inc (XCNQ:MYCO) Insider Trades Summary
Over the past 18 months, David Joshua Bartch made 2 insider transaction in Mydecine Innovations Group Inc (XCNQ:MYCO) with a net purchase of 600,000. Other recent insider transactions involving Mydecine Innovations Group Inc (XCNQ:MYCO) include a net sale of 50,000 shares made by Damon Michaels ,
In summary, during the past 3 months, insiders sold 0 shares of Mydecine Innovations Group Inc (XCNQ:MYCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,000 shares of Mydecine Innovations Group Inc (XCNQ:MYCO) were sold and 600,000 shares were bought by its insiders, resulting in a net purchase of 550,000 shares.
Mydecine Innovations Group Inc (XCNQ:MYCO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mydecine Innovations Group Inc Insider Transactions
David Joshua Bartch Mailing Address
Above is the net worth, insider trading, and ownership report for David Joshua Bartch. Currently GuruFocus does not have mailing address information for David Joshua Bartch.